Results 121 to 130 of about 371,009 (363)

Audiovestibular Dysfunction in Systemic Lupus Erythematosus Patients: A Systematic Review

Diagnostics
Audiovestibular dysfunction in patients with systemic lupus erythematosus has been underestimated for decades. Systemic lupus erythematosus can affect both the auditory and vestibular systems simultaneously.
Jiann-Jy Chen, Chih-Wei Hsu, Yen-Wen Chen, Tien-Yu Chen, Bing-Syuan Zeng, Ping-Tao Tseng   +5 more
doaj   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato, Rebecca Ross, Ranjitha Karanth, Vishal Kakkar, Enrico De Lorenzis, Lesley‐Anne Bissell, Kristina Clark, Philip Yee, Christopher P. Denton, Francesco Del Galdo   +9 more
wiley   +1 more source

Classification on Large Networks: A Quantitative Bound via Motifs and Graphons [PDF]

arXiv, 2017
When each data point is a large graph, graph statistics such as densities of certain subgraphs (motifs) can be used as feature vectors for machine learning. While intuitive, motif counts are expensive to compute and difficult to work with theoretically. Via graphon theory, we give an explicit quantitative bound for the ability of motif homomorphisms to
arxiv  

Migraine In Systemic Lupus Erythematosus in Rheumatological outpatients unit

مجله كليه طب الكندي, 2019
Background: Migraine is common in systemic lupus erythematosus.It is a significant source of patient disability. Objective: To determine the rate of migraine in patients with systemic lupus erythematosus, to assess migraine type, severity, and the ...
Ameer Shaker
doaj   +1 more source

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy

Arthritis &Rheumatology, EarlyView.
Objective The objective was to report the safety and efficacy of an anti‐IFNAR1 antibody (anifrolumab) in a patient with STING‐associated vasculopathy with onset in infancy (SAVI) who presented with vasculitic ulcers and systemic inflammation refractory to JAK inhibition (JAKi) and to the interferon‐β–neutralizing monoclonal antibody dazukibart ...
Sara Alehashemi, Bjoern Buehring, Adriana A. de Jesus, Sachin Gaurav, Andre Rastegar, Alexi Baumgardner, Kip Friend, Oluwatobi T. Arisa, William D. Figg, Danielle Fink, Douglas B. Kuhns, Ben Colton, Cody J. Peer, Raphaela Goldbach‐Mansky   +13 more
wiley   +1 more source

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

Arthritis & Rheumatology, 2017
To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE).
W. Stohl, A. Schwarting, M. Okada, M. Scheinberg, A. Doria, A. Hammer, C. Kleoudis, J. Groark, D. Bass, N. Fox, D. Roth, D. Gordon   +11 more
semanticscholar   +1 more source

Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meeting

International Journal of Women's Dermatology, 2016
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With increased interest in studying cutaneous lupus erythematosus, specifically discoid lupus erythematosus, it is our aim to apply previously adopted methods ...
Scott A. Elman, AB, Filippa Nyberg, MD, Fukumi Furukawa, MD, Mark Goodfield, MD, Minoru Hasegawa, MD, Branka Marinovic, MD, Jacek Szepietowski, MD, Jan Dutz, MD, FRCPC, Victoria P. Werth, MD, Joseph F. Merola, MD, MMSc   +9 more
doaj  

Clinical factors associated with pneumocystis pneumonia despite its primary prophylaxis: When to stop prophylaxis?

Arthritis &Rheumatology, Accepted Article.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim, Se Rim Choi, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park   +5 more
wiley   +1 more source

Visual Analytics of Group Differences in Tensor Fields: Application to Clinical DTI [PDF]

arXiv, 2017
We present a visual analytics system for exploring group differences in tensor fields with respect to all six degrees of freedom that are inherent in symmetric second-order tensors. Our framework closely integrates quantitative analysis, based on multivariate hypothesis testing and spatial cluster enhancement, with suitable visualization tools that ...
arxiv  

Global epidemiology of systemic lupus erythematosus

Nature Reviews Rheumatology, 2021
M. Barber, C. Drenkard, T. Falasinnu, A. Hoi, A. Mak, Nien Yee Kow, E. Svenungsson, Jonna Peterson, A. Clarke, R. Ramsey‐Goldman   +9 more
semanticscholar   +1 more source